Indian pharmaceutical industry will now be able to make further inroads and garner a fair share of the global market opportunity as blockbuster... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=85348&sid=1
Sudarshan Sukhani of s2analytics.com is of the view that one can buy ONGC, Sun Pharma and Aurobindo Pharma. ...http://www.moneycontrol.com/news/stocks-views/buy-ongc-sun-pharma-aurobindo-pharma-sudarshan-sukhani_1239296.html
In a chat with ET Now,Ambareesh Baliga, Market Expert, shares his views on pharma companies. ET Now: What about mid-tier pharma, do you like it?... ...http://economictimes.indiatimes.com/markets/stocks/recos/dishman-shasun-to-eye-in-mid-cap-space-says-ambareesh-baliga/articleshow/45296225.cms
Yogesh Mehta of Motilal Oswal Securities is of the view that Sun Pharmaceutical Industries may test Rs 880. ...http://www.moneycontrol.com/news/stocks-views/sun-pharma-may-test-rs-880-yogesh-mehta_1239078.html
Aluminium major Hindalco Industries topped the buying list, up 4 percent followed by Infosys, Hindustan Unilever, Sun Pharma, Mahindra Mahindra and... ...http://www.moneycontrol.com/news/local-markets/nifty-hovers-around-8470-itchdfc-drag-hindalco4_1239071.html
SMS Logistics is a sister concern of...
Discover the difference with...
NAME-BIBHUJA N MOHANTY